Shi YQ - Search Results

1

The analysis of status and clinical implication of KIT and PDGFRA mutations in gastrointestinal stromal tumor (GIST).

Du CY, Shi YQ, Zhou Y, Fu H, Zhao G. Du CY, et al. Among authors: shi yq. J Surg Oncol. 2008 Sep 1;98(3):175-8. doi: 10.1002/jso.21104. J Surg Oncol. 2008. PMID: 18618605

2

Secondary resistance to imatinib in patients with gastrointestinal stromal tumors through an acquired KIT exon 17 mutation.

Wang CM, Fu H, Zhao GF, Zhou XY, Du CY, Dong RZ, Zhou Y, Shi YQ. Wang CM, et al. Among authors: shi yq. Mol Med Rep. 2009 May-Jun;2(3):455-60. doi: 10.3892/mmr_00000121. Mol Med Rep. 2009. PMID: 21475850

3

The correlations between the expression of FGFR4 protein and clinicopathological parameters as well as prognosis of gastric cancer patients.

Ye YW, Zhang X, Zhou Y, Wu J, Zhao C, Yuan L, Wang G, Du C, Wang C, Shi Y. Ye YW, et al. J Surg Oncol. 2012 Dec;106(7):872-9. doi: 10.1002/jso.23153. Epub 2012 May 14. J Surg Oncol. 2012. PMID: 22585711

4

The role of surgery in the treatment of gastric cancer.

Shi Y, Zhou Y. Shi Y, et al. J Surg Oncol. 2010 Jun 15;101(8):687-92. doi: 10.1002/jso.21455. J Surg Oncol. 2010. PMID: 20512944 Review.

5

The fibroblast growth factor receptor-4 Arg388 allele is associated with gastric cancer progression.

Ye Y, Shi Y, Zhou Y, Du C, Wang C, Zhan H, Zheng B, Cao X, Sun MH, Fu H. Ye Y, et al. Ann Surg Oncol. 2010 Dec;17(12):3354-61. doi: 10.1245/s10434-010-1323-6. Epub 2010 Sep 16. Ann Surg Oncol. 2010. PMID: 20844967

6

[Status and clinical analysis of c-kit and PDGFRA mutations in the gastrointestinal stromal tumors].

Du CY, Shi YQ, Zhou Y, Fu H, Zhao GF. Du CY, et al. Among authors: shi yq. Zhonghua Wei Chang Wai Ke Za Zhi. 2008 Jul;11(4):371-5. Zhonghua Wei Chang Wai Ke Za Zhi. 2008. PMID: 18636362 Chinese.

7

[Surgical treatment for patients with advanced gastrointestinal stromal tumor after targeted therapy].

Wang CM, Shi YQ, Ye YW, Fu H, Zhao GF, Zhou Y, DU CY, Dong RZ. Wang CM, et al. Among authors: shi yq. Zhonghua Wei Chang Wai Ke Za Zhi. 2009 Mar;12(2):155-8. Zhonghua Wei Chang Wai Ke Za Zhi. 2009. PMID: 19296251 Chinese.

8

Prognostic factors for extra-abdominal and abdominal wall desmoids: a 20-year experience at a single institution.

Huang K, Fu H, Shi YQ, Zhou Y, Du CY. Huang K, et al. Among authors: shi yq. J Surg Oncol. 2009 Dec 1;100(7):563-9. doi: 10.1002/jso.21384. J Surg Oncol. 2009. PMID: 19722232

9

Molecular mechanisms of secondary imatinib resistance in patients with gastrointestinal stromal tumors.

Wang CM, Huang K, Zhou Y, Du CY, Ye YW, Fu H, Zhou XY, Shi YQ. Wang CM, et al. Among authors: shi yq. J Cancer Res Clin Oncol. 2010 Jul;136(7):1065-71. doi: 10.1007/s00432-009-0753-7. Epub 2009 Dec 31. J Cancer Res Clin Oncol. 2010. PMID: 20043176

10

[Oncogenic signaling mechanisms in imatinib-resistant gastrointestinal stromal tumor].

Wang CM, Shi YQ, Fu H, Zhao GF, Zhou Y, Du CY, Ye YW. Wang CM, et al. Among authors: shi yq. Zhonghua Wei Chang Wai Ke Za Zhi. 2010 May;13(5):371-4. Zhonghua Wei Chang Wai Ke Za Zhi. 2010. PMID: 20499309 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

367 results

Search Page

Filters